Factors | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
p-value | HR (95%CI) | p-value | HR (95%CI) | |
ADAM10 (Pre-NACT) | 0.147 | 1.90 (0.80–4.52) | 0.028* | 3.67 (1.15–11.70) |
ER | 0.359 | 0.84 (0.57–1.23) | 0.253 | 0.68 (0.35–1.32) |
PR | 0.246 | 0.72 (0.41–1.26) | 0.982 | 0.99 (0.45–2.19) |
HER2 | 0.727 | 0.86 (0.37–1.99) | 0.531 | 0.73 (0.28–1.94) |
Ki67 | 0.199 | 1.80 (0.73–4.43) | 0.049* | 3.33 (1.01–10.99) |
Age | 0.16 | 0.54 (0.23–1.28) | 0.553 | 0.74 (0.27–2.01) |
BMI | 0.35 | 1.48 (0.65–3.36) | 0.716 | 0.83 (0.31–2.25) |
Histological grade | 0.830 | 1.13 (0.38–3.31) | 0.112 | 2.85 (0.78–10.37) |
Tumor size | 0.002** | 4.11 (1.69–10.03) | 0.045* | 2.84 (1.02–7.88) |
Distant metastasis | 0.602 | 0.59 (0.08–4.36) | 0.528 | 0.51 (0.06–4.15) |
Lymphatic metastasis | 0.011* | 3.66 (1.35–9.94) | 0.002** | 8.13 (2.10–31.43) |
Response to NACT | 0.082 | 0.48 (0.21–1.10) | 0.993 | 1.00 (0.38–2.67) |